• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Phenylpropanolamine hydrochloride (PPA)

FDA is taking steps to remove phenylpropanolamine hydrochloride from all drug products due to the risk of hemorrhagic stroke. FDA has significant concerns because of the seriousness of stroke and the inability to predict who is at risk.

[November 6, 2000 - Public Health Advisory - FDA